T
TOT BIOPHARM International Co Ltd
HKEX:1875
TOT BIOPHARM International Co Ltd
HKEX:1875
Price:
1.87 HKD
Market Closed
Updated:
May 12, 2024
Income Statement
Earnings Waterfall
TOT BIOPHARM International Co Ltd
TOT BIOPHARM International Co Ltd
|
Revenue
|
780.6m
CNY
|
|
Cost of Revenue
|
-206.6m
CNY
|
|
Gross Profit
|
574m
CNY
|
|
Operating Expenses
|
-595.6m
CNY
|
|
Operating Income
|
-21.6m
CNY
|
|
Other Expenses
|
-16.2m
CNY
|
|
Net Income
|
-37.8m
CNY
|
Income Statement
TOT BIOPHARM International Co Ltd
TOT BIOPHARM International Co Ltd
Currency: CNY
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Revenue |
76
N/A
|
235
+208%
|
442
+88%
|
588
+33%
|
781
+33%
|
|
| Gross Profit | ||||||
| Cost of Revenue |
(49)
|
(63)
|
(72)
|
(126)
|
(207)
|
|
| Gross Profit |
27
N/A
|
172
+526%
|
371
+115%
|
462
+25%
|
574
+24%
|
|
| Operating Income | ||||||
| Operating Expenses |
(283)
|
(322)
|
(409)
|
(510)
|
(596)
|
|
| Selling, General & Administrative |
(76)
|
(137)
|
(263)
|
(399)
|
(509)
|
|
| Research & Development |
(187)
|
(196)
|
(129)
|
(131)
|
(104)
|
|
| Depreciation & Amortization |
(31)
|
0
|
(25)
|
0
|
0
|
|
| Other Operating Expenses |
11
|
11
|
9
|
21
|
18
|
|
| Operating Income |
(255)
N/A
|
(150)
+41%
|
(38)
+74%
|
(48)
-24%
|
(22)
+55%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
(0)
|
(11)
|
(9)
|
(3)
|
(5)
|
|
| Non-Reccuring Items |
(5)
|
(1)
|
(3)
|
1
|
(11)
|
|
| Pre-Tax Income |
(261)
N/A
|
(162)
+38%
|
(50)
+69%
|
(49)
+1%
|
(38)
+24%
|
|
| Net Income | ||||||
| Tax Provision |
0
|
0
|
0
|
(0)
|
(0)
|
|
| Income from Continuing Operations |
(261)
|
(162)
|
(50)
|
(49)
|
(38)
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(261)
N/A
|
(162)
+38%
|
(50)
+69%
|
(49)
+1%
|
(38)
+23%
|
|
| EPS (Diluted) |
-0.46
N/A
|
-0.28
+39%
|
-0.08
+71%
|
-0.07
+13%
|
-0.05
+29%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
